{
  "created_at": "Thu Aug 26 12:20:18 +0000 2021",
  "id_str": "1430855063149457411",
  "full_text": "Under a new deal with Pfizer and BioNTech, Brazil’s Eurofarma will produce at least 100 million vaccine doses annually for distribution in Latin America https://t.co/SH9bYzfG9Z",
  "display_text_range": [
    0,
    176
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/SH9bYzfG9Z",
        "expanded_url": "https://on.wsj.com/2Wkj1Ed",
        "display_url": "on.wsj.com/2Wkj1Ed",
        "indices": [
          153,
          176
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 34,
  "favorite_count": 98,
  "possibly_sensitive": false,
  "original_created_at": "Thu Aug 26 11:30:05 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "Pfizer社およびBioNTech社との新たな契約に基づき、ブラジルのEurofarma社は、ラテンアメリカでの流通のために、少なくとも年間1億本のワクチンを製造する https://t.co/SH9bYzfG9Z"
    },
    {
      "locale": "zh",
      "full_text": "根据与辉瑞公司和BioNTech的新协议，巴西的Eurofarma公司每年将生产至少1亿剂疫苗，在拉丁美洲销售https://t.co/SH9bYzfG9Z。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "根據與輝瑞公司和BioNTech的新協議，巴西的Eurofarma公司每年將生產至少1億劑疫苗，在拉丁美洲銷售https://t.co/SH9bYzfG9Z。"
    }
  ]
}